St. Johns Investment Management Company, LLC Kintara Therapeutics, Inc. Transaction History

St. Johns Investment Management Company, LLC

  • $213 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022
SELL
$0.31 - $0.55 $38 - $68
-125 Closed
0 $0
Q3 2021

Nov 04, 2021
BUY
$0.82 - $2.3 $102 - $287
125 New
125 $0

About Kintara Therapeutics, Inc.

KTRA Quotes by TradingView
  • Ticker KTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,807,296
  • Market Cap $17.8M
  • Description
  • Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...
More about KTRA
Track This Portfolio

Track St. Johns Investment Management Company, LLC Portfolio

Follow St. Johns Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Johns Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on St. Johns Investment Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email